{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:53:41Z","timestamp":1781952821779,"version":"3.54.5"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["KLI 1015-B"],"award-info":[{"award-number":["KLI 1015-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Over the past decades, adapted lifestyle and dietary habits in industrialized countries have led to a progress of obesity and associated metabolic disorders. Concomitant insulin resistance and derangements in lipid metabolism foster the deposition of excess lipids in organs and tissues with limited capacity of physiologic lipid storage. In organs pivotal for systemic metabolic homeostasis, this ectopic lipid content disturbs metabolic action, thereby promotes the progression of metabolic disease, and inherits a risk for cardiometabolic complications. Pituitary hormone syndromes are commonly associated with metabolic diseases. However, the impact on subcutaneous, visceral, and ectopic fat stores between disorders and their underlying hormonal axes is rather different, and the underlying pathophysiological pathways remain largely unknown. Pituitary disorders might influence ectopic lipid deposition indirectly by modulating lipid metabolism and insulin sensitivity, but also directly by organ specific hormonal effects on energy metabolism. In this review, we aim to I) provide information about the impact of pituitary disorders on ectopic fat stores, II) and to present up-to-date knowledge on potential pathophysiological mechanisms of hormone action in ectopic lipid metabolism.<\/jats:p>","DOI":"10.3389\/fendo.2023.1075776","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T05:33:30Z","timestamp":1676266410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Ectopic lipid metabolism in anterior pituitary dysfunction"],"prefix":"10.3389","volume":"14","author":[{"given":"Clemens","family":"Baumgartner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kr\u0161\u0161\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greisa","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2017.4","article-title":"What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications","volume":"41","author":"Cuthbertson","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0031","article-title":"Heart, lipids and hormones","volume":"6","author":"Wolf","year":"2017","journal-title":"Endocrine Connections"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(87)90063-1","article-title":"Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity","volume":"36","author":"Fujioka","year":"1987","journal-title":"Metabolism"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: An update","volume":"126","author":"Despr\u00e9s","year":"2012","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2013.07.017","article-title":"Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function","volume":"95","author":"Guebre-Egziabher","year":"2013","journal-title":"Biochimie"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2011.605387","article-title":"Mapping body fat distribution: A key step towards the identification of the vulnerable patient","volume":"44","author":"Arsenault","year":"2012","journal-title":"Ann Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2242","article-title":"No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy","volume":"99","author":"Winhofer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151301","article-title":"Pericardial- rather than intramyocardial fat is independently associated with left ventricular systolic heart function in metabolically healthy humans. eckel J, herausgeber","volume":"11","author":"Wolf","year":"2016","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in cushing\u2019s syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00479","article-title":"Adipose tissues and thyroid hormones","volume":"5","author":"Obregon","year":"2014","journal-title":"Front Physiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocrine Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/dom.14206","article-title":"Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review","volume":"23","author":"Dandona","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0030","article-title":"Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist","volume":"7","author":"Athanasoulia-Kaspar","year":"2018","journal-title":"Endocrine Connections"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.626427","article-title":"The interaction of insulin and pituitary hormone syndromes","volume":"12","author":"Schernthaner-Reiter","year":"2021","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13143","article-title":"Glucose and lipid metabolism abnormalities in C ushing\u2019s syndrome","volume":"34","author":"Salehidoost","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: Pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.04.014","article-title":"Current and emerging aspects of diabetes mellitus in acromegaly","volume":"27","author":"Frara","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/er.2018-00163","article-title":"Thyroid dysfunction and diabetes mellitus: Two closely associated disorders","volume":"40","author":"Biondi","year":"2019","journal-title":"Endocrine Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/a-1258-8625","article-title":"The effect of pituitary gland disorders on glucose metabolism: From pathophysiology to management","volume":"53","author":"Sydney","year":"2021","journal-title":"Horm Metab Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000314272","article-title":"Metabolic syndrome in cushing\u2019s syndrome","volume":"92","author":"Chanson","year":"2010","journal-title":"Neuroendocrinology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1819-6","article-title":"Factors predicting long-term comorbidities in patients with cushing\u2019s syndrome in remission","volume":"64","author":"Schernthaner-Reiter","year":"2019","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00018-022-04169-6","article-title":"Regulatory mechanisms of the early phase of white adipocyte differentiation: An overview","volume":"79","author":"Audano","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from the inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0381","article-title":"Adipocyte glucocorticoid receptor deficiency attenuates aging- and HFD-induced obesity and impairs the feeding-fasting transition","volume":"66","author":"Mueller","year":"2017","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.207","article-title":"Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue","volume":"16","author":"Lee","year":"2008","journal-title":"Obesity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2011","article-title":"Omental adipose tissue type 1 11\u03b2-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women","volume":"94","author":"Veilleux","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-16-0513","article-title":"Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones","volume":"234","author":"Geisler","year":"2017","journal-title":"J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02228","article-title":"Adipose tissue 11 \u03b2-hydroxysteroid dehydrogenase type 1 expression in obesity and cushing\u2019s syndrome","volume":"155","author":"Mariniello","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1297","article-title":"Changes in adenosine 5\u2032-monophosphate-activated protein kinase as a mechanism of visceral obesity in cushing\u2019s syndrome","volume":"93","author":"Kola","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.09.014","article-title":"Twenty-eight-day bed rest with hypercortisolemia induces peripheral insulin resistance and increases intramuscular triglycerides","volume":"59","author":"Cree","year":"2010","journal-title":"Metabolism"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.831831","article-title":"Diurnal salivary cortisol in relation to body composition and heart rate variability in young adults","volume":"13","author":"Cvijetic","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"dgz329","DOI":"10.1210\/clinem\/dgz329","article-title":"Thigh muscle fat infiltration is associated with impaired physical performance despite remission in cushing\u2019s syndrome","volume":"105","author":"Martel-Duguech","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of cushing\u2019s syndrome: State of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S247379","article-title":"Glucocorticoid-induced fatty liver disease","volume":"13","author":"Rahimi","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02154.x","article-title":"Relationship of nonalcoholic hepatic steatosis to overnight low-dose dexamethasone suppression test in obese individuals","volume":"61","author":"Zoppini","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in cushing\u2019s syndrome: a radiological assessment using computed tomography","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10091790","article-title":"Assessment of hepatic steatosis in patients undergoing liver resection: Comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1 h MR spectroscopy","volume":"256","author":"van Werven","year":"2010","journal-title":"Radiology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00493-5","article-title":"Left ventricular structural and functional characteristics in cushing\u2019s syndrome","volume":"41","author":"Muiesan","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1783","article-title":"Cardiac structure and function in cushing\u2019s syndrome: A cardiac magnetic resonance imaging study","volume":"99","author":"Kamenick\u00fd","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab556","article-title":"Epicardial and pericardial adiposity without myocardial steatosis in cushing\u2019s syndrome","volume":"106","author":"Wolf","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.07.096","article-title":"Cushing syndrome is associated with subclinical LV dysfunction and increased epicardial adipose tissue","volume":"72","author":"Maurice","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01324","article-title":"Visceral fat and novel biomarkers of cardiovascular disease in patients with addison\u2019s disease: A case-control study","volume":"102","author":"Bergthorsdottir","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12020-019-01974-1","article-title":"Plasma renin levels are associated with cardiac function in primary adrenal insufficiency","volume":"65","author":"Wolf","year":"2019","journal-title":"Endocrine"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106304","article-title":"Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects","volume":"49","author":"Braverman","year":"1970","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2312","article-title":"Hyperthyroidism increases brown fat metabolism in humans","volume":"99","author":"Lahesmaa","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200111775","article-title":"Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle","volume":"108","author":"Lebon","year":"2001","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0254","article-title":"Thyroid hormone and adipocyte differentiation","volume":"18","author":"Obregon","year":"2008","journal-title":"Thyroid"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1300","article-title":"Thyroid function and the risk of nonalcoholic fatty liver disease: The Rotterdam study","volume":"101","author":"Bano","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J Hepatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1152\/ajpendo.00573.2012","article-title":"Thyroid hormone receptor-\u03b2 agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways","volume":"305","author":"Vatner","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31296","article-title":"Thyroid hormone signaling and the liver","volume":"72","author":"Ritter","year":"2020","journal-title":"Hepatology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2112","article-title":"Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function","volume":"99","author":"Scherer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa663","article-title":"Effects of thyroid function on phosphodiester concentrations in skeletal muscle and liver: An In vivo NMRS study","volume":"105","author":"Beiglb\u00f6ck","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00288.2005","article-title":"Thyroid hormone controls myocardial substrate metabolism through nuclear receptor-mediated and rapid posttranscriptional mechanisms","volume":"290","author":"Hyyti","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)41152-6","article-title":"Expression of lipoprotein lipase in rat muscle: regulation by feeding and hypothyroidism","volume":"35","author":"Ong","year":"1994","journal-title":"J Lipid Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cen.13042","article-title":"Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement","volume":"85","author":"Meienberg","year":"2016","journal-title":"Clin Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0280-9","article-title":"The effects of growth hormone on adipose tissue: old observations, new mechanisms","volume":"16","author":"Kopchick","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1530\/JME-18-0076","article-title":"40 YEARS of IGF1: Understanding the tissue-specific roles of IGF1\/IGF1R in regulating metabolism using the Cre\/loxP system","volume":"61","author":"Kineman","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2063","article-title":"Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity","volume":"98","author":"Bredella","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","first-page":"117862641770399","DOI":"10.1177\/1178626417703995","article-title":"The role of the growth Hormone\/Insulin-like growth factor system in visceral adiposity","volume":"10","author":"Lewitt","year":"2017","journal-title":"Biochem Insights"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2005.07.011","article-title":"Insulin-like growth factor I, growth hormone and insulin in white adipose tissue","volume":"19","author":"Bl\u00fcher","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2780","article-title":"Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly","volume":"93","author":"Freda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0900","article-title":"Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study","volume":"186","author":"Wolf","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1917","article-title":"Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment","volume":"100","author":"Reyes-Vidal","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00509","article-title":"Insulin resistance in patients with acromegaly","volume":"10","author":"Vila","year":"2019","journal-title":"Front Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e134638","DOI":"10.1172\/jci.insight.134638","article-title":"Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly","volume":"5","author":"Fellinger","year":"2020","journal-title":"JCI Insight"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0370","article-title":"Growth hormone inhibits hepatic de novo lipogenesis in adult mice","volume":"64","author":"Cordoba-Chacon","year":"2015","journal-title":"Diabetes"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00669","article-title":"Adult-onset hepatocyte GH resistance promotes NASH in Male mice, without severe systemic metabolic dysfunction","volume":"159","author":"Cordoba-Chacon","year":"2019","journal-title":"Endocrinology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031474","article-title":"Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: A stable isotope study","volume":"89","author":"Christ","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00374.2006","article-title":"Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics","volume":"292","author":"Krag","year":"2007","journal-title":"Am J Physiology-Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/endo.131.6.1446613","article-title":"In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver","volume":"131","author":"Elam","year":"1992","journal-title":"Endocrinology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"101332","DOI":"10.1016\/j.ghir.2020.101332","article-title":"Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression","author":"Villanueva-Ortega","year":"2020","journal-title":"Growth Hormone IGF Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"P1719-1731.E5","DOI":"10.1016\/j.cmet.2022.09.020","article-title":"Leptin increases hepatic triglyceride export via a vagal mechanism in humans","volume":"34","author":"Metz","year":"2022","journal-title":"Cell Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.933039","article-title":"The acromegaly lipodystrophy","volume":"13","author":"Freda","year":"2022","journal-title":"Front Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: An endocrine society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.orcp.2011.09.001","article-title":"Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone deficiency without diabetes mellitus","volume":"6","author":"Sato","year":"2012","journal-title":"Obes Res Clin Pract"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1532","article-title":"Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency","volume":"99","author":"Yuen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00092.2003","article-title":"Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients","volume":"285","author":"N\u00f8rrelund","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.02.008","article-title":"Sex differences in adipose tissue function","volume":"49","author":"Gavin","year":"2020","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0124","article-title":"MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease","volume":"177","author":"Schiffer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.04.008","article-title":"Understanding androgen action in adipose tissue","volume":"143","author":"O\u2019Reilly","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.828780","article-title":"Metabolic and epigenetic regulation by estrogen in adipocytes","volume":"13","author":"Bjune","year":"2022","journal-title":"Front Endocrinol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/EJE-13-0296","article-title":"Non-alcoholic fatty liver disease in common endocrine disorders","volume":"169","author":"Hazlehurst","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc15-1518","article-title":"Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes","volume":"39","author":"Dhindsa","year":"2016","journal-title":"Diabetes Care"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2807","article-title":"Acute and short-term chronic testosterone fluctuation effects on glucose homeostasis, insulin sensitivity, and adiponectin: A randomized, double-blind, placebo-controlled, crossover study","volume":"99","author":"H\u00f8st","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0440","article-title":"Independent effects of testosterone on lipid oxidation and VLDL-TG production","volume":"62","author":"H\u00f8st","year":"2013","journal-title":"Diabetes"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199902010-00005","article-title":"Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss","volume":"20","author":"Strawford","year":"1999","journal-title":"J Acquired Immune Deficiency Syndromes Hum Retrovirol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0071","article-title":"MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial","volume":"177","author":"Magnussen","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1000159","DOI":"10.4172\/2167-7182.1000159","article-title":"Testosterone supplementation improves carbohydrate and lipid metabolism in some older men with abdominal obesity","volume":"3","author":"Sattler","year":"2014","journal-title":"J gerontol geriatric Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/07435801003705601","article-title":"Impact of acute biochemical castration on insulin sensitivity in healthy adult men","volume":"35","author":"Rabiee","year":"2010","journal-title":"Endocrine Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"New Engl J Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1482","article-title":"Short-term estrogen withdrawal increases adiposity in healthy men","volume":"101","author":"Chao","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031327","article-title":"Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. implications for the female fat distribution","volume":"89","author":"Pedersen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0053","article-title":"Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals","volume":"94","author":"Moro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00069\/abstract","article-title":"Fatty infiltration of skeletal muscle: Mechanisms and comparisons with bone marrow adiposity","volume":"7","author":"Hamrick","year":"2016","journal-title":"Front Endocrinol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0296","article-title":"Mechanisms in endocrinology: Non-alcoholic fatty liver disease in common endocrine disorders","volume":"169","author":"Hazlehurst","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24374","article-title":"The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer","volume":"115","author":"Saphner","year":"2009","journal-title":"Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.572490","article-title":"Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: Relevance of estrogen signaling","volume":"11","author":"Della Torre","year":"2020","journal-title":"Front Endocrinol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2649","article-title":"Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men","volume":"100","author":"Pramfalk","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn9886","article-title":"An evolutionary trade-off between host immunity and metabolism drives fatty liver in male mice","volume":"378","author":"Nikkanen","year":"2022","journal-title":"Science"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00403.x","article-title":"Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels: Prolactin and increased body weight","volume":"48","author":"Greenman","year":"1998","journal-title":"Clin Endocrinol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"Santos-Silva","year":"2011","journal-title":"Obesity"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.6.667","article-title":"Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects","volume":"19","author":"Cincotta","year":"1996","journal-title":"Diabetes Care"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12204","article-title":"Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels","volume":"79","author":"Ciresi","year":"2013","journal-title":"Clin Endocrinol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.83058","article-title":"Bromocriptine in type 2 diabetes mellitus","volume":"15","author":"Shivaprasad","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"B119","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/eje.0.1470077","article-title":"Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine","volume":"147","author":"Doknic","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012879","article-title":"Nonalcoholic fatty liver disease with prolactin-secreting pituitary adenoma in an adolescent: A case report","volume":"97","author":"Takaki","year":"2018","journal-title":"Medicine"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062252","article-title":"Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a retrospective analysis of patients from a single hospital in China","volume":"12","author":"Zhang","year":"2022","journal-title":"BMJ Open"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J Hepatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1075776\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T05:33:34Z","timestamp":1676266414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1075776\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":122,"alternative-id":["10.3389\/fendo.2023.1075776"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1075776","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"article-number":"1075776"}}